CK-0045

N/A

Report date: 2024/12/12 16:37:26

Base Information

Drug NameCK-0045
Drug Alias NameCK-0045
ClassificationBiologics > Protein drugs
Mechanisms of ActionInterleukin-22 receptor agonists
TargetsInterleukin-22 receptor
Therapy Area/IndicationsOverweightObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumGermany
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCytoki Pharma ApS
China Registration ClassN/A

Develop Information

Active CompaniesCytoki Pharma ApS
Inactive CompaniesN/A
Active IndicationsOverweightObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A